Bank Of New York Mellon Corp Galapagos Nv Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	BUY	$76.15 - $111.94 $41,197 - $60,559	541 Added 6.95%	8,327 $641,000
Q4 2020 Feb 09, 2021	SELL	$96.85 - $148.25 $146,534 - $224,302	-1,513 Reduced 16.27%	7,786 $770,000
Q3 2020 Nov 12, 2020	BUY	$122.47 - $213.56 $154,189 - $268,872	1,259 Added 15.66%	9,299 $1.32 Million
Q2 2020 Aug 12, 2020	BUY	$185.52 - $231.25 $936,319 - $1.17 Million	5,047 Added 168.63%	8,040 $1.59 Million
Q1 2020 May 06, 2020	BUY	$143.0 - $274.03 $37,323 - $71,521	261 Added 9.55%	2,993 $586,000
Q4 2019 Feb 14, 2020	SELL	$146.12 - $215.82 $10.6 Million - $15.6 Million	-72,266 Reduced 96.36%	2,732 $565,000
Q3 2019 Nov 07, 2019	SELL	$130.44 - $187.64 $22.3 Million - $32.1 Million	-171,129 Reduced 69.53%	74,998 $11.4 Million
Q2 2019 Aug 12, 2019	SELL	$111.45 - $128.93 $1.51 Million - $1.75 Million	-13,575 Reduced 5.23%	246,127 $31.7 Million
Q1 2019 May 14, 2019	BUY	$89.61 - $117.78 $946,729 - $1.24 Million	10,565 Added 4.24%	259,702 $30.6 Million
Q4 2018 Feb 11, 2019	BUY	$87.81 - $110.65 $18.4 Million - $23.2 Million	209,642 Added 530.81%	249,137 $22.9 Million
Q3 2018 Nov 09, 2018	SELL	$90.63 - $120.22 $14,047 - $18,634	-155 Reduced 0.39%	39,495 $0
Q2 2018 Aug 06, 2018	BUY	$88.4 - $105.34 $3,624 - $4,318	41 Added 0.1%	39,650 $3.66 Million
Q1 2018 May 15, 2018	BUY	$94.51 - $120.23 $15,405 - $19,597	163 Added 0.41%	39,609 $3.95 Million
Q4 2017 Feb 09, 2018	BUY	$84.48 - $104.02 $3.33 Million - $4.1 Million	39,446	39,446 $3.7 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.